Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | HPGD | P15428 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | THRA | P10827 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | STS | P08842 | 4/20 | 0.55 |
| ▸ | HSD17B3 | P37058 | 6/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4020524 | 1.00 | ALDH1A1 (0.67) | ALDH1A1CYP1A2HPGDCYP2C19HSD17B10 | |
| SCHEMBL16672058 | 1.00 | ALDH1A1 (0.67) | ALDH1A1CYP1A2HPGDCYP2C19HSD17B10 | |
| SCHEMBL10574043 | 0.98 | ALDH1A1 (0.68) | ALDH1A1CYP1A2HPGDCYP2C19HSD17B10 | |
| SCHEMBL10415403 | 0.94 | ALDH1A1 (0.70) | ALDH1A1CYP1A2HPGDCYP2C19HSD17B10 | |
| SCHEMBL9805743 | 0.88 | CYP1A2 (0.81) | ALDH1A1CYP1A2HPGDCYP2C19HSD17B10 | |
| SCHEMBL9805821 | 0.88 | CYP1A2 (0.81) | ALDH1A1CYP1A2HPGDCYP2C19HSD17B10 | |
| SCHEMBL9805771 | 0.88 | THRA (0.56) | ALDH1A1CYP1A2HPGDCYP2C19HSD17B10 | |
| SCHEMBL11465372 | 0.88 | CYP2C19 (0.74) | ALDH1A1CYP1A2HPGDCYP2C19HSD17B10 | |
| SCHEMBL6344166 | 0.87 | THRA (0.55) | ALDH1A1CYP1A2HPGDCYP2C19HSD17B10 | |
| SCHEMBL6340900 | 0.87 | THRA (0.55) | ALDH1A1CYP1A2HPGDCYP2C19HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7511167-B2 | Two-photon dyes for real-time imaging of lipid rafts | Korea University Industry and Academy Cooperation Foundation (KR) | 2009-03-31 | — | — | US | disclosed |
| US-20080071106-A1 | Two-photon dyes for real-time imaging of lipid rafts | Korea University Industry and Academy Cooperation Foundation (KR) | 2008-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080071106-A1 | Two-photon dyes for real-time imaging of lipid rafts | LAMP2, FLOT1, NPC1L1 | ALDH1A1 3083/4885CYP1A2 3609/4885HPGD 1822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.